JAN 18, 2018 7:57 AM PST

Treatment of a Childhood Cancer: An Overview

WRITTEN BY: Courtney Schaal

Ewing sarcoma is an aggressive cancer of the bone and soft tissue occurring primarily in adolescents and young adults, although not exclusively. Over the years, doctors treating Ewing sarcoma patients have increased survival rates through the use of intense chemotherapy cocktails and surgical resection for localized tumors; however, there is still a bleak and dismal outcome for patients with metastatic disease. Additionally, there are undesirable and noteworthy toxicities associated with chemotherapies used. In order to improve survival outcome and quality of life for these patients, the field demands development of better therapeutic options. We are beginning to understand the biological processes underlying this disease, which will undoubtedly help to move the field forward.

Ewing sarcoma is largely thought to originate from cancerous transformation of stem cells during development. Essentially, stem cells gone awry. This cancer is known to be driven by a chromosomal translocation resulting in a fusion protein that acts to turn on and off genes that normally would not be turned on or off. Targeting of this fusion protein itself in theory would provide an ideal means by which to combat the disease, but due to its lack of certain features it is difficult to target with small molecule compounds. Researchers have been attempting to target it, or its downstream and in some cases up stream effectors; however, large progresses are still elusive.

Recently, epigenetic deregulation has been implicated more and more in the progression of this disease and many labs working on Ewing sarcoma have begun to focus largely on being able to target this. LSD1, for example, is a lysine demethylase which acts to remove repressive marks off of silent genes allowing them to become activated and turn on, and it is found to be overexpressed in Ewing sarcoma. This has become a promising novel therapeutic target and intervention being investigated by academic labs in addition to large and small pharmaceutical companies, and its entering clinical trials. Additionally, there are academic labs conducting screens of epigenetic-targeting compound libraries to identify any which might be useful in combating Ewing sarcoma. So far HDAC inhibitors have been published as hits, and other novel compounds are under investigation. DNA methyltransferases also show promise for therapeutic benefit in this tumor type.

As knowledge expands into the biology of the disease, and as other therapeutics such as immunotherapies and RNA interference are being investigated in addition to epigenetic-focused therapies, the promise of new and improved treatment modalities to extend lifespan and improve quality of life is high. These efforts will hopefully favorably impact patient outcomes in the near future.

Sources: Critical Reviews in Oncology, Pixabay, Youtube, Summon Info Point

 

About the Author
You May Also Like
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
NOV 12, 2020
Technology
The Crossover of Virtual Reality and Drug Discovery
NOV 12, 2020
The Crossover of Virtual Reality and Drug Discovery
Researchers have recently developed a unique virtual reality (VR) tool that can help in drug development? Particularly, ...
NOV 18, 2020
Drug Discovery & Development
Hepatitis C Drugs May Be Involved Coronavirus Treatment
NOV 18, 2020
Hepatitis C Drugs May Be Involved Coronavirus Treatment
At the present moment, there are no inhibitors that target protease activity of the novel SARS-CoV-2. The main proteases ...
NOV 26, 2020
Cannabis Sciences
Women More Likely than Men to Swap Prescription Medication for Cannabis
NOV 26, 2020
Women More Likely than Men to Swap Prescription Medication for Cannabis
The stigma around cannabis usage is fading as cannabis laws become increasingly lax. Now, researchers from DePaul Univer ...
DEC 09, 2020
Technology
AI Helps Drug Combination Therapy in Cancer
DEC 09, 2020
AI Helps Drug Combination Therapy in Cancer
Healthcare providers opt to multiple of therapies for cancer patients—often containing combo drugs. Research has s ...
JAN 21, 2021
Health & Medicine
Injectable Cannabis Overdose Drug Being Developed
JAN 21, 2021
Injectable Cannabis Overdose Drug Being Developed
It’s estimated that the number of visits to emergency rooms because of cannabis overdose tripled between 2011 and ...
Loading Comments...